|
|
|
HR0868 |
|
LRB096 19601 KXB 34993 r |
|
|
1 |
| HOUSE RESOLUTION
|
2 |
| WHEREAS, The prescription of psychotropic drugs to treat |
3 |
| psychiatric disorders has greatly increased in recent years; |
4 |
| and
|
5 |
| WHEREAS, The U.S. Food and Drug Administration has, since |
6 |
| 2004, required manufacturers of selective serotonin reuptake |
7 |
| inhibitor antidepressant medications (SSRIs) to add black box |
8 |
| warnings to their product labeling, advising that studies have |
9 |
| shown an increase in suicidal thinking and behavior among |
10 |
| children and adolescents suffering from psychiatric disorders; |
11 |
| and
|
12 |
| WHEREAS, Health authorities in Canada, the European Union, |
13 |
| Australia, and Great Britain have issued warnings regarding the |
14 |
| increased risk of self-harm or harm to others associated with |
15 |
| SSRIs; and
|
16 |
| WHEREAS, In recent years there have been numerous |
17 |
| documented instances of suicides and acts of violence against |
18 |
| others by persons reported to have been taking antidepressants |
19 |
| and/or other psychotropic medications; therefore, be it
|
20 |
| RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE |
21 |
| NINETY-SIXTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that |
|
|
|
HR0868 |
- 2 - |
LRB096 19601 KXB 34993 r |
|
|
1 |
| the Psychotropic Substances Suicide Risk Task Force be created |
2 |
| within the Department of Public Health to (1) study and report |
3 |
| upon the available research relevant to the reputed causal link |
4 |
| between prescription of psychotropic substances and acts of |
5 |
| suicide or violence against others; (2) to evaluate whether the |
6 |
| State of Illinois' current policies with regard to psychotropic |
7 |
| substances are adequate to protect the public; and (3) to make |
8 |
| recommendations as to whether Illinois should consider |
9 |
| adopting additional policies with regard to psychotropic |
10 |
| substances, including but not limited to requiring county |
11 |
| coroners to test for psychotropic substances in cases of |
12 |
| suspected suicide; and be it further
|
13 |
| RESOLVED, That the Task Force shall consist of the |
14 |
| following members: 3 members appointed by the Speaker of the |
15 |
| House of Representatives, one of whom shall be appointed |
16 |
| co-chairperson, and 3 members appointed by the Minority Leader |
17 |
| of the House of Representatives, one of whom shall be appointed |
18 |
| co-chairperson; and 2 members appointed by the Director of the |
19 |
| Department of Public Health; and be it further |
20 |
| RESOLVED, That the Task Force shall take voluntary |
21 |
| assistance and testimony from individuals and/or professional |
22 |
| organizations and institutions; and be it further |
23 |
| RESOLVED, That the members of the Task Force shall serve |